hero section gradient
16 handpicked stocks

Industrial Automation: Thriving In A Manufacturing Slowdown

The continued contraction of the U.S. manufacturing sector highlights a critical need for operational efficiency. This situation creates a potential investment opportunity in companies providing automation, robotics, and other cost-saving technologies to the industrial sector.

Author avatar

Han Tan | Market Analyst

Published on August 2

Your Basket's Financial Footprint

Market cap breakdown for the Industrial Automation basket and key investor takeaways.

Key Takeaways for Investors:
  • Large-cap dominance generally implies lower volatility and closer tracking to broad market performance, reducing idiosyncratic risk.
  • Best used as a core portfolio holding for steady industrial-automation exposure, not as a speculative trade.
  • Expect steady, long-term appreciation rather than explosive short-term gains; growth will likely be moderate.
Total Market Cap
  • ROK: $39.82B

  • EMR: $74.39B

  • TEL: $67.43B

  • Other

About This Group of Stocks

1

Our Expert Thinking

When manufacturing faces headwinds, companies turn to technology for survival. This group focuses on businesses that provide essential automation, robotics, and efficiency solutions that manufacturers desperately need during economic pressure. It's a tactical approach to investing in necessity-driven technology adoption.

2

What You Need to Know

These stocks represent companies that help factories cut costs and boost productivity through advanced technology. With the U.S. manufacturing sector contracting for five consecutive months, these efficiency-enhancing solutions become more valuable, not less. This creates a unique investment dynamic during economic slowdowns.

3

Why These Stocks

Each company was handpicked by professional analysts for their role in industrial transformation. They specialise in automation, robotics, and supply chain optimisation - the exact technologies manufacturers need to stay competitive when traditional growth strategies aren't working. These aren't random picks, but strategic selections based on market necessity.

Why You'll Want to Watch These Stocks

🔧

Necessity Drives Demand

When manufacturers are struggling, they don't stop investing - they invest smarter. These automation companies provide the cost-cutting solutions that factories absolutely need to survive economic pressure.

📈

Counter-Cyclical Opportunity

While traditional manufacturing stocks suffer during slowdowns, efficiency technology becomes more valuable. This creates a unique investment angle where economic headwinds actually strengthen the business case.

🤖

Future-Proof Technology

These companies aren't just surviving the current downturn - they're building the infrastructure for tomorrow's factories. Robotics and automation represent the long-term evolution of manufacturing.

Get the full story on this Basket. Read our detailed article on its risks and potential.

Read Full Insight

Why Invest with Nemo Money?

Nemo Logo Fade
🆓

Zero Commission

Trade stocks, ETFs, and more with zero commission. Keep more of your returns.

🔒

Trusted & Regulated

Part of Exinity Group 2015, serving over a million customers globally.

💰

6% Interest on Cash

Earn 6% AER on uninvested cash with daily interest payments.

Discover More Opportunities

Automotive Semiconductor Gap Explained | Market Shift

Automotive Semiconductor Gap Explained | Market Shift

A major semiconductor supplier's export ban from China is halting vehicle production, creating a potential opening for other chip manufacturers. This theme identifies alternative semiconductor companies poised to fill the critical supply gap for the automotive industry.

Brazil Smart Farming Tech Investment Basket 2025

Brazil Smart Farming Tech Investment Basket 2025

As Brazil solidifies its role as a global agricultural leader, advanced technologies are unlocking new levels of productivity and sustainability for its farms. This basket offers exposure to the US and EU-listed companies providing the essential hardware, software, and data analytics driving this transformation.

Weight-Loss Drug M&A: Valuation Risk Concerns

Weight-Loss Drug M&A: Valuation Risk Concerns

Novo Nordisk's superior bid for Metsera has ignited a bidding war with Pfizer, highlighting the intense M&A activity in the obesity drug market. This theme focuses on other biotech companies with promising weight-loss therapies that could become the next acquisition targets.

Frequently Asked Questions